GlassScriptPhysician profile
Hannah Edwards
NPI 1164100665
$725.19
in general payments reported to CMS, 2019-2025
14 companies · $340 in 2025
The $340 reported for 2025 was more than what 78% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $385 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.19 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $116.95 | 2024 | |
| Radius Health, INC. | $95.08 | 2024-2025 | Tymlos |
| Sumitomo Pharma America, INC. | $73.85 | 2024-2025 | Myfembree, Gemtesa |
| Baxter Healthcare | $69.52 | 2025 | Perclot |
| Astellas Pharma US INC | $66.82 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $65.69 | 2024-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Novasure |
| Organon LLC | $47.30 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $39.30 | 2025 | Austedo Xr |
| Mayne Pharma Commercial LLC | $33.35 | 2024-2025 | |
| Dexcom, INC. | $28.85 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $28.02 | 2024 | |
| Lundbeck LLC | $22.89 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.87 | 2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $14.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.